Old Web
English
Sign In
Acemap
>
Paper
>
EP15 Switching to biosimilar adalimumab: a real world study
EP15 Switching to biosimilar adalimumab: a real world study
2020
Julie Begum
Muhammad K. Nisar
Keywords:
cost savings
Reliability engineering
Biosimilar
Tumor necrosis factors
Adalimumab
Physical therapy
Medicine
treatment outcome
Biosimilar Pharmaceuticals
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]